Want to join the conversation?
$EW 2Q15 Call: Strong second quarter performance led by underlying sales growth of 18%, significant global TAVR therapy adaption drove our results and also boosted by surgical valve and critical care product lines. During the quarter, we are pleased to receive U.S. approval of SAPIEN 3.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!